Wuhan Healthgen Biotechnology Corp. (SHA:688765)

China · Delayed Price · Currency is CNY

36.60

-0.13 (-0.35%)

At close: Sep 4, 2026

SHA:688765 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	23.39	25.22	24.26	13.4	25.52	21.57
Revenue Growth	-3.62%	3.92%	81.08%	-47.49%	18.33%	110.40%
Gross Profit	11.33	15.53	12.06	7.22	15.62	15.3
Operating Income	-177.75	-166.45	-207.66	-163.04	-131.18	-62.74
Net Income	-160.81	-151.37	-186.96	-143.58	-134.04	-53.35
Earnings Per Share	-0.59	-0.56	-0.70	-0.55	-0.62	-1.07
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
China	12.18	9.63	6.6	9.64	7.44
Overseas	13.04	14.64	6.8	15.88	14.13
Total	25.22	24.26	13.4	25.52	21.57

Cash & Debt

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Investments	74.82	160.4	235.97	387.56	243.41	150.71
Total Debt	606.67	222.93	93.93	15.25	0.76	10.01
Net Cash (Debt)	-531.85	-62.53	142.04	372.31	242.65	140.69
Net Cash Growth	-	-	-61.85%	53.44%	72.47%	5104.02%
Net Cash Per Share	-1.97	-0.23	0.53	1.43	1.12	2.82

Cash Flow & CapEx

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Cash Flow	-123.7	-53.53	-122.85	-66.4	-87.97	-35.18
Capital Expenditures	-345.93	-166.84	-101.59	-358.29	-175.47	-1.66
Free Cash Flow	-469.63	-220.38	-224.45	-424.7	-263.44	-36.85
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Gross Margin	48.43%	61.59%	49.71%	53.89%	61.21%	70.95%
Operating Margin	-760.04%	-660.11%	-855.82%	-1216.74%	-514.08%	-290.94%
Pretax Margin	-687.60%	-600.28%	-770.53%	-1071.49%	-525.26%	-247.39%
Profit Margin	-687.60%	-600.28%	-770.53%	-1071.49%	-525.26%	-247.39%
FCF Margin	-2008.10%	-873.96%	-925.01%	-3169.45%	-1032.38%	-170.86%